Regarding immune checkpoints associated with tumor cell immune evasion, such as CTLA-4, PD-1, PD-L1, TIGIT, these inhibitory receptors/ligands suppress antitumor immune responses by altering their expression levels (Xing et al., 2021). The gene discussed is CTLA4; the disease is neoplasm.